Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A1 | P22736 | 1/20 | 0.60 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.60 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | GLA | P06280 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.55 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acridine SCHEMBL29774329 | 0.98 | NR4A1 (0.58) | NR4A1NR4A2NR4A3ALDH1A1KMT2A | |
| Acridine SCHEMBL31147690 | 0.98 | NR4A1 (0.58) | NR4A1NR4A2NR4A3ALDH1A1KMT2A | |
| Hydrochloric Acid SCHEMBL9083721 | 0.98 | NR4A1 (0.58) | NR4A1NR4A2NR4A3ALDH1A1KMT2A | |
| Water SCHEMBL7769203 | 0.98 | NR4A1 (0.58) | NR4A1NR4A2NR4A3ALDH1A1KMT2A | |
| SCHEMBL8850857 | 0.98 | NR4A1 (0.58) | NR4A1NR4A2NR4A3ALDH1A1KMT2A | |
| SCHEMBL9424973 | 0.91 | ALDH1A1 (0.53) | NR4A1NR4A2NR4A3ALDH1A1KMT2A | |
| SCHEMBL27356901 | 0.89 | ALDH1A1 (0.55) | NR4A1NR4A2NR4A3ALDH1A1KMT2A | |
| SCHEMBL5352931 | 0.87 | ALDH1A1 (0.53) | NR4A1NR4A2NR4A3ALDH1A1KMT2A | |
| SCHEMBL3296316 | 0.86 | KMT2A (0.54) | NR4A1NR4A2NR4A3ALDH1A1KMT2A | |
| SCHEMBL3535241 | 0.86 | ALDH1A1 (0.51) | NR4A1NR4A2NR4A3ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 306 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121574095-A | Double-band acridine formate anthracene methyl ester photocatalyst and preparation method and application thereof | 江西初源新材料有限公司 | 2026-02-27 | — | — | CN | claimed |
| WO-2023103464-A1 | ZINC TRANSPORTER 8 ANTIBODY CHEMILUMINESCENCE IMMUNOASSAY KIT AND PREPARATION METHOD THEREOF | 深圳市亚辉龙生物科技股份有限公司 | 2023-06-15 | — | — | WO | claimed |
| CN-106146672-B | Acridine marks conjugate and preparation method thereof, chemiluminescence immune detection reagent kit | 深圳市亚辉龙生物科技股份有限公司 | 2019-11-29 | — | — | CN | claimed |
| US-20190309030-A1 | ACRIDINE LABELLED CONJUGATES AND PREPARATION METHODS THEREFOR AND CHEMILUMINESCENT KITS | SHENZHEN YHLO BIOTECH CO LTD (CN) | 2019-10-10 | — | — | US | claimed |
| US-20190175566-A1 | ANTI-TUMOR COCKTAIL COMPRISING AN ANTI-TUMOR AGENT SELECTIVE FOR TUMOR ACIDITY, AN ANTIOXIDANT, AND A P-GLYCOPROTEIN INHIBITOR | ARION TECNOLOGIA BRASIL - GESTÃO DE ATIVOS S/A (BR) | 2019-06-13 | — | — | US | claimed |
| EP-3483172-A1 | ACRIDINE-MARKER CONJUGATE AND PREPARATION METHOD THEREOF, AND CHEMILUMINESCENCE KIT | Shenzhen Yhlo Biotech Co., Ltd (CN) | 2019-05-15 | — | — | EP | claimed |
| CN-109709336-A | A kind of detection kit and detection method of vascular endothelial growth factor | 张嘉庆 | 2019-05-03 | — | — | CN | claimed |
| CN-107810184-A | Light emitting device and compound | 圣安德鲁斯大学董事会 | 2018-03-16 | — | — | CN | claimed |
| EP-1301485-B1 | NOVEL HETEROARYL DERIVATIVES AND THE USE THEREOF AS PHARMACEUTICALS | ZENTARIS GMBH (DE) | 2007-06-27 | — | — | EP | claimed |
| US-20050009809-A1 | Aryl- and heteroaryl-substituted piperazinylcarbonyl acridines and their homologs, e.g., (1,3-dihydroxyacridin-9-yl)-[4-(6-methyl pyridin-2-yl )piperazin-1-yl]methanone,are suitable for treating benign and malignant tumors | ZENTARIS GMBH (DE) | 2005-01-13 | — | — | US | claimed |
| EP-0621788-A4 | HEMOREGULATORY PEPTIDES. | SMITHKLINE BEECHAM CORP (US) | 1997-03-05 | — | — | EP | claimed |
| EP-0725651-A4 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORP (US) | 1997-03-05 | — | — | EP | claimed |
| EP-0725651-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1996-08-14 | — | — | EP | claimed |
| EP-0701446-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1996-03-20 | — | — | EP | claimed |
| WO-1995011693-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1995-05-04 | — | — | WO | claimed |
| WO-1994027627-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1994-12-08 | — | — | WO | claimed |
| WO-1994028420-A1 | METHOD OF DETECTION OF BACTERIA | RHONE POULENC DIAGNOSTICS LTD (GB) | 1994-12-08 | — | — | WO | claimed |
| EP-0621788-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1994-11-02 | — | — | EP | claimed |
| WO-1993013789-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1993-07-22 | — | — | WO | claimed |
| EP-0273115-A2 | Chemiluminescent acridinium and phenanthridinium salts | ABBOTT LABORATORIES (US) | 1988-07-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190309030-A1 | ACRIDINE LABELLED CONJUGATES AND PREPARATION METHODS THEREFOR AND CHEMILUMINESCENT KITS | ACR, GOT1, HLCS | NR4A1 3300/4885NR4A2 3996/4885NR4A3 4007/4885 |
| US-20050009809-A1 | Aryl- and heteroaryl-substituted piperazinylcarbonyl acridines and their homologs, e.g., (1,3-dihydroxyacridin-9-yl)-[4-(6-methyl pyridin-2-yl )piperazin-1-yl]methanone,are suitable for treating benign and malignant tumors | PKD1, MDH2, MSH2 | NR4A1 140/4885NR4A2 272/4885NR4A3 540/4885 |
| US-20190175566-A1 | ANTI-TUMOR COCKTAIL COMPRISING AN ANTI-TUMOR AGENT SELECTIVE FOR TUMOR ACIDITY, AN ANTIOXIDANT, AND A P-GLYCOPROTEIN INHIBITOR | ABCG2, SDHA, ABCB1 | NR4A1 3123/4885NR4A2 3271/4885NR4A3 3103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.